Τρέχουσες Κλινικές Μελέτες

(Κύριος Ερευνητής: Αθανάσιος Αργύρης)

E1305 “A phase III randomized trial of Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer”, NCT00588770


S1206 “A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy with Carboplatin, and Paclitaxel for Unresectable, Stage III Non-Small Cell Lung Cancer”, NCT01386385


CheckMate 651. "An Open Label, Randomized, Two Arm Phase III Study of Nivolumab in Combination with Ipilimumab versus Extreme Study Regimen (cetuximab + cisplatin/carboplatin + fluorouracil) as First Line Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)"